Literature DB >> 26311241

Gremlin1 and chronic pancreatitis: a new clinical target and biomarker?

Derek P Brazil1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26311241     DOI： 10.1007/s00109-015-1335-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  28 in total

Review 1.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 2.  Chronic pancreatitis.

Authors:  Joan M Braganza; Stephen H Lee; Rory F McCloy; Michael J McMahon
Journal:  Lancet       Date:  2011-04-02       Impact factor: 79.321

3.  Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.

Authors:  Stefania Mitola; Cosetta Ravelli; Emanuela Moroni; Valentina Salvi; Daria Leali; Kurt Ballmer-Hofer; Luca Zammataro; Marco Presta
Journal:  Blood       Date:  2010-07-21       Impact factor: 22.113

4.  Co-regulation of Gremlin and Notch signalling in diabetic nephropathy.

Authors:  David W Walsh; Sarah A Roxburgh; Paul McGettigan; Celine C Berthier; Desmond G Higgins; Matthias Kretzler; Clemens D Cohen; Sergio Mezzano; Derek P Brazil; Finian Martin
Journal:  Biochim Biophys Acta       Date:  2007-10-11

5.  Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo.

Authors:  Outi Leppäranta; Jussi M Tikkanen; Maxim M Bespalov; Katri Koli; Marjukka Myllärniemi
Journal:  Am J Respir Cell Mol Biol       Date:  2013-04       Impact factor: 6.914

6.  The epidemiology of alcohol-induced pancreatitis.

Authors:  Mary C Dufour; Megan D Adamson
Journal:  Pancreas       Date:  2003-11       Impact factor: 3.327

Review 7.  Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy.

Authors:  Heiko Witt; Minoti V Apte; Volker Keim; Jeremy S Wilson
Journal:  Gastroenterology       Date:  2007-04       Impact factor: 22.682

8.  In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7.

Authors:  Qingxian Zhang; Yonghong Shi; Jun Wada; Sandra M Malakauskas; Maodong Liu; Yunzhuo Ren; Chunyang Du; Huijun Duan; Yingmin Li; Ying Li; Yanling Zhang
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

9.  The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.

Authors:  Hong Namkoong; Seung Min Shin; Hyun Kee Kim; Seon-Ah Ha; Goang Won Cho; Soo Young Hur; Tae Eung Kim; Jin Woo Kim
Journal:  BMC Cancer       Date:  2006-03-18       Impact factor: 4.430

10.  Gremlin, a bone morphogenetic protein antagonist, is a crucial angiogenic factor in pituitary adenoma.

Authors:  Kenta Koketsu; Daizo Yoshida; Kyongsong Kim; Yudo Ishii; Shigeyuki Tahara; Akira Teramoto; Akio Morita
Journal:  Int J Endocrinol       Date:  2015-03-05       Impact factor: 3.257
View more
  2 in total

1.  Human esophageal myofibroblast secretion of bone morphogenetic proteins and GREMLIN1 and paracrine regulation of squamous epithelial growth.

Authors:  Chunying Zhang; Chao Niu; Kevin Yang; Anisa Shaker
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

2.  Gremlin Regulates Tubular Epithelial to Mesenchymal Transition via VEGFR2: Potential Role in Renal Fibrosis.

Authors:  Laura Marquez-Exposito; Carolina Lavoz; Raul R Rodrigues-Diez; Sandra Rayego-Mateos; Macarena Orejudo; Elena Cantero-Navarro; Alberto Ortiz; Jesús Egido; Rafael Selgas; Sergio Mezzano; Marta Ruiz-Ortega
Journal:  Front Pharmacol       Date:  2018-10-17       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.